Neurobiology of Aging
Volume 24, Issue 1 , Pages 57-65 , January 2003

Oxidative stress-mediated DHEA formation in Alzheimer’s disease pathology

  • Rachel C Brown

      Affiliations

    • The Interdisciplinary Program in Neuroscience, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC 20007, USA
    • Present address: Department of Pharmacology, University of Arizona Medical Center, Tucson, AZ 85724, USA.
    • ,
  • Zeqiu Han

      Affiliations

    • Division of Hormone Research, Department of Cell Biology, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC 20007, USA
    • ,
  • Caterina Cascio

      Affiliations

    • Division of Hormone Research, Department of Cell Biology, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC 20007, USA
    • Present address: Institute of Neuropsychiatry, School of Medicine, University of Palermo, Palermo, Italy.
    • ,
  • Vassilios Papadopoulos

      Affiliations

    • The Interdisciplinary Program in Neuroscience, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC 20007, USA
    • Division of Hormone Research, Department of Cell Biology, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC 20007, USA
    • Departments of Pharmacology and Neuroscience, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC 20007, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-202-687-8991; fax: +1-202-687-7855.

Received 28 November 2001 ,Revised 1 February 2002 ,Accepted 21 February 2002.

References 

  1. Akwa Y, Young J, Kabbadj K, Sancho MJ, Zucman D, Vourc’h C, et al.  Neurosteroids: biosynthesis, metabolism and function of pregnenolone and dehydroepiandrosterone in the brain. J. Steroid. Biochem. Molec. Biol. 1991;40(1–3):71–81
  2. Baulieu EE. Dehydroepiandrosterone (DHEA): a fountain of youth?. J. Clin. Endocrinol. Metab. 1996;81(9):3147–3151
  3. Baulieu E-E, Robel P. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J. Endocrinol. 1996;150:S221–S239
  4. Baulieu E-E, Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAs) as neuroactive neurosteroids. Proc. Natl. Acad. Sci. U.S.A. 1998;95:4089–4091
  5. Bergeron R, Montigny CD, Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated by sigma receptors. J. Neurosci. 1996;16(3):1193–1202
  6. Berr C, Lafont S, Debuire B, Dartigues J-F, Baulieu E-E. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a french community-based study. PNAS. 1996;93:13410–13415
  7. Bjorkhem I, Lutjohann D, Breuer O, Sakinis A, Wennmalm A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18o2 techniques in vivo and in vitro. J. Biol. Chem. 1997;272(48):30178–30184
  8. Brown RC, Cascio C, Papadopoulos V. Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide. J. Neurochem. 2000;74(2):847–859
  9. Canning DR, McKeon RJ, De Witt DA, Perry G, Wujek JR, Frederickson RC, et al.  β-Amyloid of Alzheimer’s disease induces reactive gliosis that inhibits axonal outgrowth. Exp. Neurol. 1993;124(2):289–298
  10. Cardounel A, Regelson W, Kalimi M. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc. Soc. Exp. Biol. Med. 1999;222(2):145–149
  11. Cascio C, Brown RC, Liu Y, Han Z, Hales DB, Papadopoulos VV. Pathways of dehydroepiandrosterone formation in rat brain glia. J. Steroid Biochem. Mol. Biol. 2000;75(2–3):177–186
  12. Cascio C, Prasad VV, Lin YY, Lieberman S, Papadopoulos V. Detection of P450c17-independent pathways for dehydroepiandrosterone (DHEA) biosynthesis in brain glial tumor cells. Proc. Natl. Acad. Sci. U.S.A. 1998;95(6):2862–2867
  13. Compagnone NA, Bulfone A, Rubenstein JLR, Mellon SH. Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system. Endocrinology. 1995;136(11):5212–5223
  14. Corpechot C, Robel P, Axelson M, Sjovall J, Baulieu E-E. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. U.S.A. 1981;78(8):4704–4707
  15. Flood JF, Morley JE, Roberts E. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. PNAS. 1992;89(5):1567–1571
  16. Garnier M, Boujrad N, Oke BO, Brown AS, Riond J, Ferrara P, et al.  Diazepam binding inhibitor is a paracrine/autocrine regulator of leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms. Endocrinology. 1993;132(1):444–458
  17. Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J. Clin. Endocrinol. Metab. 1996;81(11):3951–3960
  18. Hales DB, Sha LL, Payne AH. Testosterone inhibits camp-induced de novo synthesis of leydig cell cytochrome P450(17 alpha) by an androgen receptor-mediated mechanism. J. Biol. Chem. 1987;262(23):11200–11206
  19. Huang X, Atwood C, Hartshorn M, Multhaup G, Goldstein L, Scarpa R, et al.  The Aβ peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 1999;38(24):7609–7616
  20. Joachim CL, Selkoe DJ. The seminal role of β-amyloid in the pathogenesis of Alzheimer’s disease. Alzheimer Dis. Assoc. Disord. 1992;6(1):7–34
  21. Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Hervert J. Dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAs) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1998;95:1852–1857
  22. Lacroix C, Fiet J, Benais J-P, Gueux B, Bonete R, Villette J-M, et al.  Simultaneous radioimmunoassay of progesterone, androst-4-enedione, pregnenolone, dehydroepiandrosterone and 17-hydroxyprogesterone in specific regions of human brain. J. Steroid Biochem. 1987;28(3):317–325
  23. Lanthier A, Paatwardhan VV. Sex steroids and 5-en-3beta-hydroxysteroids in specific regions of the human brain and cranial nerves. J. Steroid Biochem. 1986;25(3):445–449
  24. LeGoascogne C, Sananes N, Gouezou M, Takemori S, Kominami S, Baulieu EE, et al.  Immunoreactive cytochrome P450 17α in rat and Guinea pig gonads, adrenal glands and brain. J. Reprod. Fertil. 1991;93:609–622
  25. Lutjohann D, Papassotiropoulos A, Bjorkhem I, Locatelli S, Bagli M, Oehring RD, et al.  Plasma 24(S)-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 2000;41(2):195–198
  26. Majewska MD, Demirgoren S, Spivak CE, London ED. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res. 1990;526:143–146
  27. Markesbery WR. Oxidative stress hypothesis in Alzheimer’s disease. Free Rad. Biol. Med. 1997;23(1):134–147
  28. Mecocci P, MacGarvey U, Beal M. Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann. Neurol. 1994;36(5):747–751
  29. Mellon SH, Deschepper CF. Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res. 1993;629:283–292
  30. Nunomura A, Perry G, Pappolla MA, Friedland RP, Hirai K, Chiba S, et al.  Neuronal oxidative stress precedes amyloid-beta deposition in down syndrome. J. Neuropathol. Exp. Neurol. 2000;59(11):1011–1017
  31. Parker CR. Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids. 1999;64(9):640–647
  32. Prasad VVK, Vegesna SR, Welch M, Lieberman S. Precursors of the neurosteroids. Proc. Natl. Acad. Sci. U.S.A. 1994;91:3220–3223
  33. Smith MA, Harris PL, Sayre LM, Perry G. Iron accumulation in Alzheimer’s disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U.S.A. 1997;94(18):9866–9868
  34. Smith MA, Rudnicka-Nawrot M, PL R, Praprotnik D, Mulvihill P, Miller C, et al.  Carbonyl-related post-translational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer’s disease. J. Neurochem. 1995;64(6):2660–2666
  35. Stromstedt M, Waterman MR. Messenger RNAs encoding steroidogenic enzymes are expressed in rodent brain. Mol. Brain Res. 1995;34:75–88
  36. Subbarao K, Richardson J, Ang L. Autopsy samples of Alzheimer’s cortex show increased peroxidation in vitro. J. Neurochem. 1990;55(1):205–228
  37. Wolf OT, Koster B, Kirschbaum C, Pietrowsky R, Kern W, Hellhammer DH, et al.  A single administration of dehydroepiandrosterone does not enhance memory performance in young healthy adults, but immediately reduces cortisol levels. Biol. Psychiatry. 1997;42(9):845–848
  38. Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendorfer RA, et al.  Effects of a 2-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J. Clin. Endocrinol. Metab. 1997;82(7):2363–2367
  39. Yoo A, Harris J, Dubrovsky B. Dose-response study of dehydroepiandrosterone sulfate on dentate gyrus long-term potentiation. Exp. Neurol. 1996;137:151–156

PII: S0197-4580(02)00048-9

Neurobiology of Aging
Volume 24, Issue 1 , Pages 57-65 , January 2003

Article Tools

* Image Usage & Resolution